1. Herberman RB, Thurman GB: Approaches to the immunological monitoring of cancer patients treated with natural or recombinant interferons. J Biol Response Mod 2: 548–562, 1983.
2. Currie GA: Immunological aspects of human cancer, in Lachmann PJ, Peters DK (eds): Clinical aspects of immunology, ed 4. Oxford, Blackwell Scientific Publ, 1982, pp 1279–1298.
3. Field EJ, Caspary EA: Lymphocyte sensitization: an in vitrotest for cancer? Lancetii: 1337–1341, 1970.
4. Ax W: Tumor diagnosis using electrophoretic mobility test (EMT). Review on state of the art with references to the use of stabilized erythrocytes as indicator particles, in Flad HD, Herfath C, Betzler M (eds): Immuno-diagnosis and immunotherapy of malignant tumors. Relevance to surgery. Berlin, Springer-Verlag, 1979, pp 169–183.
5. Pritchard JAV, Moore JL, Sutherland WH, Joslin CAF: Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease. Br J Cancer 27: 1–9, 1973.